Trial intelligence / Profile preview

Immediate Postpartum DMPA in Breastfeeding Women

NCT03844633Phase 4Terminated

Sponsor
The Ohio State University
Start
Mar 2019
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of medroxyprogesterone acetate in unintended pregnancy, sponsored by The Ohio State University. Started Mar 2019; status: terminated.

02

Drugs

medroxyprogesterone acetate
03

Conditions

unintended pregnancy

Beyond the preview

Go deeper on NCT03844633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03844633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call